Form 4: Amedisys Director Samuels Receives Stock Units

Director Ivanetta Davis Samuels receives 1,690 restricted stock units from Amedisys Inc.

Summary

• Ivanetta Davis Samuels, a director of Amedisys Inc., received 1,690 time-based Restricted Stock Units (RSUs) on May 3, 2025.
• Each RSU represents a contingent right to receive one share of Amedisys' common stock.
• The RSUs will vest 100% on May 3, 2026, contingent upon Samuels' continued service as a non-employee member of the Issuer's Board of Directors through the vesting date.
• Following the transaction, Samuels directly owns 7,600 shares of Amedisys Inc. common stock.

Sentiment

Score: 6

Explanation: The document reflects a neutral sentiment as it is a standard regulatory filing detailing the granting of stock units to a company director. It doesn't inherently indicate positive or negative performance.

Positives

• The awarding of RSUs to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
• The vesting period of one year encourages the director's continued service and commitment to the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency into the compensation and ownership structure of the company's directors.

Stakeholder Impact

• The granting of RSUs to a director can have a positive impact on shareholders by aligning the director's interests with the company's long-term success.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Amedisys, Director, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, Samuels, Insider Trading